You stopped SOPA and PIPA!
You did it! You stopped SOPA and PIPA in their tracks. You delivered a wake up call to Congress! If ever I doubted the power of the people, I stand corrected now. For weeks it has looked as if the PROTECT IP Act (PIPA) and Stop Online Piracy Act (SOPA) would fast track to an easy passage despite the lack of full and balanced hearings (never included tech experts) and criticism from the tech industry, consumer rights groups, entrepreneurs, and academics.
While neither bill is dead, your efforts have certainly made their passage less likely. The momentum of these bills that would cut off access to affordable medicine has stalled. Almost universally, legislators have cited the earful they got from their constituents as reasoning for this turn of events. They’re worried about angering you in an election year—let’s keep them worried!
Your letters, emails, phone calls and visits to your Congresspeople made a difference. Last Wednesday, MILLIONS joined you in speaking out to express opposition to the bills during the big Internet blackout. In response to your powerful actions, the House and the Senate have put the bills on hold. Congratulations on a job well done and thank you for standing up for affordable medicine!
Find out where members of Congress stand on SOPA/PIPA. ProPublica has put together some helpful information detailing who supports and opposes the bills. You can also find out about their industry campaign contributions (Computers/Internet vs. TV/Movies/Music).
Remember to thank your representatives in Congress if they stood up to reject these bills (and remind those who haven’t that you still expect them to). We’re heartened to know that so many members of Congress have listened to their constituents.
Though the fight isn’t over, we should take a moment to reflect on the momentum and strength we have gained—this is a big victory!
As always, we promise to keep you posted on future developments. Thanks again for your support. What a great way to begin a new year!
Lee GraczykLead Organizer, RxRights
This article was originally featured in the RxRights e-newsletter. Sign up for the newsletter.